Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2012

Open Access 01-12-2012 | Research article

Sesquiterpene lactones isolated from indigenous Middle Eastern plants inhibit tumor promoter-induced transformation of JB6 cells

Authors: Melody Saikali, Akram Ghantous, Racha Halawi, Salma N Talhouk, Najat A Saliba, Nadine Darwiche

Published in: BMC Complementary Medicine and Therapies | Issue 1/2012

Login to get access

Abstract

Background

Sesquiterpene lactones (SL) are plant secondary metabolites that are known for their anti-fungal, anti-bacterial, anti-inflammatory, and anti-tumor properties. Considering that several SL-derived drugs are currently in cancer clinical trials, we have tested two SL molecules, 3-β-methoxy-iso-seco-tanapartholide (β-tan) isolated from Achillea falcata and salograviolide A (Sal A) isolated from Centaurea ainetensis, for their anti-tumor properties. We used the mouse epidermal JB6P + cells as a model for tumor promotion and cellular transformation. Key players that are involved in cellular transformation and tumorigenesis are the AP-1 and NF-κB transcription factors; therefore, we assessed how β-tan and Sal A modulate their signaling pathways in JB6P + cells.

Methods

The effects of β-tan and Sal A on the growth of normal and neoplastic keratinocytes and on the tumor promotion-responsive JB6P + cells were determined using the MTT assay. Anchorage-independent cell growth transformation assays were used to evaluate the anti-tumor promoting properties of these SL molecules in JB6P + cells and dual luciferase reporter assays and western blot analysis were used to investigate their effects on tumor promoter-induced AP-1 and NF-κB activities and protein levels of key AP-1 and NF-кB target genes.

Results

β-tan and Sal A selectively inhibited tumor promoter-induced cell growth and transformation of JB6P + cells at concentrations that do not affect JB6P + and primary keratinocytes basal cell growth. In addition, both molecules reduced basal and tumor promoter-induced NF-κB transcriptional activities, differentially regulated basal and tumor promoter-induced AP-1 transcriptional activities, and modulated key players of the AP-1 and NF-κB signaling pathways.

Conclusions

These results highlight the anti-tumor promoting properties of β-tan and Sal A. These SL molecules isolated from two plant species native to the Middle East may provide opportunities for complementary medicine practices.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harvey AL: Natural products in drug discovery. Drug Discovery Today. 2008, 13: 894-901. 10.1016/j.drudis.2008.07.004.CrossRefPubMed Harvey AL: Natural products in drug discovery. Drug Discovery Today. 2008, 13: 894-901. 10.1016/j.drudis.2008.07.004.CrossRefPubMed
2.
go back to reference Shah B, Seth A, Maheshwari K: A review on medicinal plants as a source of anti-inflammatory agents. Journal of Medicinal Plants Research. 2011, 5: 101-115.CrossRef Shah B, Seth A, Maheshwari K: A review on medicinal plants as a source of anti-inflammatory agents. Journal of Medicinal Plants Research. 2011, 5: 101-115.CrossRef
3.
go back to reference Darwiche N, El-Banna S, Gali-Muhtasib H: Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development. Expert Opinion on Drug Discovery. 2007, 2: 361-379. 10.1517/17460441.2.3.361.CrossRefPubMed Darwiche N, El-Banna S, Gali-Muhtasib H: Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development. Expert Opinion on Drug Discovery. 2007, 2: 361-379. 10.1517/17460441.2.3.361.CrossRefPubMed
5.
go back to reference Merfort I: Perspectives on sesquiterpene lactones in inflammation and cancer. Current Drug Targets. 2011, 12: 1560-73. 10.2174/138945011798109437.CrossRefPubMed Merfort I: Perspectives on sesquiterpene lactones in inflammation and cancer. Current Drug Targets. 2011, 12: 1560-73. 10.2174/138945011798109437.CrossRefPubMed
6.
go back to reference Zhang S, Won YK, Ong CN, Shen HM: Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Current Medicinal Chemistry-Anti-Cancer Agents. 2005, 5: 239-249. 10.2174/1568011053765976.CrossRefPubMed Zhang S, Won YK, Ong CN, Shen HM: Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Current Medicinal Chemistry-Anti-Cancer Agents. 2005, 5: 239-249. 10.2174/1568011053765976.CrossRefPubMed
7.
go back to reference Kaij-a-Kamb M, Amoros M, Girre L: Search for new antiviral agents of plant origin. Pharmaceutica acta Helvetiae. 1992, 67: 130-147.PubMed Kaij-a-Kamb M, Amoros M, Girre L: Search for new antiviral agents of plant origin. Pharmaceutica acta Helvetiae. 1992, 67: 130-147.PubMed
8.
go back to reference Gurib-Fakim A: Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular aspects of Medicine. 2006, 27: 1-93. 10.1016/j.mam.2005.07.008.CrossRefPubMed Gurib-Fakim A: Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular aspects of Medicine. 2006, 27: 1-93. 10.1016/j.mam.2005.07.008.CrossRefPubMed
9.
go back to reference Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N: What made sesquiterpene lactones reach cancer clinical trials?. Drug Discovery Today. 2010, 15: 668-678. 10.1016/j.drudis.2010.06.002.CrossRefPubMed Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N: What made sesquiterpene lactones reach cancer clinical trials?. Drug Discovery Today. 2010, 15: 668-678. 10.1016/j.drudis.2010.06.002.CrossRefPubMed
10.
go back to reference Ghantous A, Tayyoun AA, Lteif GA, Saliba NA, Gali-Muhtasib H, El-Sabban M, Darwiche N: Purified Salograviolide A isolated from Centaurea ainetensis causes growth inhibition and apoptosis in neoplastic epidermal cells. International Journal of Oncology. 2008, 32: 841-849.PubMed Ghantous A, Tayyoun AA, Lteif GA, Saliba NA, Gali-Muhtasib H, El-Sabban M, Darwiche N: Purified Salograviolide A isolated from Centaurea ainetensis causes growth inhibition and apoptosis in neoplastic epidermal cells. International Journal of Oncology. 2008, 32: 841-849.PubMed
11.
go back to reference Ghantous A, Nasser N, Saab I, Darwiche N, Saliba NA: Structure–activity relationship of seco-tanapartholides isolated from Achillea falcata for inhibition of HaCaT cell growth. European Journal of Medicinal Chemistry. 2009, 44: 3794-3797. 10.1016/j.ejmech.2009.04.029.CrossRefPubMed Ghantous A, Nasser N, Saab I, Darwiche N, Saliba NA: Structure–activity relationship of seco-tanapartholides isolated from Achillea falcata for inhibition of HaCaT cell growth. European Journal of Medicinal Chemistry. 2009, 44: 3794-3797. 10.1016/j.ejmech.2009.04.029.CrossRefPubMed
12.
go back to reference El-Najjar N, Dakdouki S, Darwiche N, El-Sabban M, Saliba NA, Gali-Muhtasib H: Anti-colon cancer effects of Salograviolide A isolated from Centaurea ainetensis. Oncology Reports. 2008, 19: 897-904.PubMed El-Najjar N, Dakdouki S, Darwiche N, El-Sabban M, Saliba NA, Gali-Muhtasib H: Anti-colon cancer effects of Salograviolide A isolated from Centaurea ainetensis. Oncology Reports. 2008, 19: 897-904.PubMed
13.
go back to reference Talhouk RS, El-Jouni1 W, Baalbaki R, Gali-Muhtasib H, Kogan J, Talhouk S: Anti-inflammatory bio-activities in water extract of Centaurea ainetensis. Journal of Medicinal Plants Research. 2008, 2: 024-033. Talhouk RS, El-Jouni1 W, Baalbaki R, Gali-Muhtasib H, Kogan J, Talhouk S: Anti-inflammatory bio-activities in water extract of Centaurea ainetensis. Journal of Medicinal Plants Research. 2008, 2: 024-033.
14.
go back to reference Saliba NA, Dakdouki S, Homeidan F, Kogan J, Bouhadir K, Talhouk S, Talhouk R: Bio-guided identification of an anti-inflammatory guaianolide from Centaurea ainetensis. Pharmaceutical Biology. 2009, 47: 701-707. 10.1080/13880200902933021.CrossRef Saliba NA, Dakdouki S, Homeidan F, Kogan J, Bouhadir K, Talhouk S, Talhouk R: Bio-guided identification of an anti-inflammatory guaianolide from Centaurea ainetensis. Pharmaceutical Biology. 2009, 47: 701-707. 10.1080/13880200902933021.CrossRef
15.
go back to reference Nehmé M: Wild flowers of Lebanon. 1977, National Council for Scientific Research, Beirut, NCSR Beirut (Lebanon) Nehmé M: Wild flowers of Lebanon. 1977, National Council for Scientific Research, Beirut, NCSR Beirut (Lebanon)
16.
go back to reference Al-Saghir J, Al-Ashi R, Salloum R, Saliba NA, Talhouk RS, Homaidan FR: Anti-inflammatory properties of Salograviolide A purified from Lebanese plant Centaurea ainetensis. BMC Complementary and Alternative Medicine. 2009, 9: 36-10.1186/1472-6882-9-36.CrossRefPubMedPubMedCentral Al-Saghir J, Al-Ashi R, Salloum R, Saliba NA, Talhouk RS, Homaidan FR: Anti-inflammatory properties of Salograviolide A purified from Lebanese plant Centaurea ainetensis. BMC Complementary and Alternative Medicine. 2009, 9: 36-10.1186/1472-6882-9-36.CrossRefPubMedPubMedCentral
17.
go back to reference Gali-Muhtasib H, Fakhoury I: Salograviolide A: A Plant-Derived Sesquiterpene Lactone with Promising Anti-Inflammatory and Anticancer Effects. Advances in Cancer Therapy. Edited by: Gali-Muhtasib H. 2011, InTech, 388, 369-388.CrossRef Gali-Muhtasib H, Fakhoury I: Salograviolide A: A Plant-Derived Sesquiterpene Lactone with Promising Anti-Inflammatory and Anticancer Effects. Advances in Cancer Therapy. Edited by: Gali-Muhtasib H. 2011, InTech, 388, 369-388.CrossRef
18.
go back to reference Colburn NH, Former BF, Nelson KA, Yuspa SH: Tumour promoter induces anchorage independence irreversibly. Nature. 1979, 281: 589-591. 10.1038/281589a0.CrossRefPubMed Colburn NH, Former BF, Nelson KA, Yuspa SH: Tumour promoter induces anchorage independence irreversibly. Nature. 1979, 281: 589-591. 10.1038/281589a0.CrossRefPubMed
19.
go back to reference Dhar A, Young MR, Colburn NH: The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Molecular and Cellular Biochemistry. 2002, 234–235: 185-193.CrossRefPubMed Dhar A, Young MR, Colburn NH: The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Molecular and Cellular Biochemistry. 2002, 234–235: 185-193.CrossRefPubMed
20.
go back to reference Huang J, Plass C, Gerhäuser C: Cancer chemoprevention by targeting the epigenome. Current Drug Targets. 2010, 12: 1925-1956.CrossRef Huang J, Plass C, Gerhäuser C: Cancer chemoprevention by targeting the epigenome. Current Drug Targets. 2010, 12: 1925-1956.CrossRef
21.
go back to reference Huang YW, Kuo CT, Stoner K, Huang TH, Wang LS: An overview of epigenetics and chemoprevention. FEBS Lett. 2011, 585: 2129-2136. 10.1016/j.febslet.2010.11.002.CrossRefPubMed Huang YW, Kuo CT, Stoner K, Huang TH, Wang LS: An overview of epigenetics and chemoprevention. FEBS Lett. 2011, 585: 2129-2136. 10.1016/j.febslet.2010.11.002.CrossRefPubMed
22.
go back to reference Colburn NH: Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism. Carcinogenesis. 1980, 1: 951-954. 10.1093/carcin/1.11.951.CrossRefPubMed Colburn NH: Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism. Carcinogenesis. 1980, 1: 951-954. 10.1093/carcin/1.11.951.CrossRefPubMed
23.
go back to reference Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH: Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proceedings of the National Academy of Sciences. 1994, 91: 609-613. 10.1073/pnas.91.2.609.CrossRef Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH: Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proceedings of the National Academy of Sciences. 1994, 91: 609-613. 10.1073/pnas.91.2.609.CrossRef
24.
go back to reference Weber TJ, Siegel RW, Markillie LM, Chrisler WB, Lei XC, Colburn NH: A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells. Molecular Carcinogenesis. 2005, 43: 31-37. 10.1002/mc.20092.CrossRefPubMed Weber TJ, Siegel RW, Markillie LM, Chrisler WB, Lei XC, Colburn NH: A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells. Molecular Carcinogenesis. 2005, 43: 31-37. 10.1002/mc.20092.CrossRefPubMed
25.
go back to reference Li JJ, Westergaard C, Ghosh P, Colburn NH: Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Research. 1997, 57: 3569-3576.PubMed Li JJ, Westergaard C, Ghosh P, Colburn NH: Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Research. 1997, 57: 3569-3576.PubMed
26.
go back to reference Young MR, Li JJ, Rincón M, Flavell RA, Sathyanarayana BK, Hunziker R, Colburn NH: Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proceedings of the National Academy of Sciences. 1999, 96: 9827-9832. 10.1073/pnas.96.17.9827.CrossRef Young MR, Li JJ, Rincón M, Flavell RA, Sathyanarayana BK, Hunziker R, Colburn NH: Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proceedings of the National Academy of Sciences. 1999, 96: 9827-9832. 10.1073/pnas.96.17.9827.CrossRef
27.
go back to reference Hsu TC, Nair R, Tulsian P, Camalier CE, Hegamyer GA, Young MR, Colburn NH: Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-κB activation. Cancer Research. 2001, 61: 4160-4168.PubMed Hsu TC, Nair R, Tulsian P, Camalier CE, Hegamyer GA, Young MR, Colburn NH: Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-κB activation. Cancer Research. 2001, 61: 4160-4168.PubMed
28.
go back to reference Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH: Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 1998, 17: 3493-3498.CrossRefPubMed Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH: Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 1998, 17: 3493-3498.CrossRefPubMed
29.
go back to reference Hsu TC, Young MR, Cmarik J, Colburn NH: Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radical Biology and Medicine. 2000, 28: 1338-1348. 10.1016/S0891-5849(00)00220-3.CrossRefPubMed Hsu TC, Young MR, Cmarik J, Colburn NH: Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radical Biology and Medicine. 2000, 28: 1338-1348. 10.1016/S0891-5849(00)00220-3.CrossRefPubMed
30.
go back to reference Young MR, Yang HS, Colburn NH: Promising molecular targets for cancer prevention: AP-1, NF-[kappa] B and Pdcd4. Trends in Molecular Medicine. 2003, 9: 36-41. 10.1016/S1471-4914(02)00009-6.CrossRefPubMed Young MR, Yang HS, Colburn NH: Promising molecular targets for cancer prevention: AP-1, NF-[kappa] B and Pdcd4. Trends in Molecular Medicine. 2003, 9: 36-41. 10.1016/S1471-4914(02)00009-6.CrossRefPubMed
31.
go back to reference Yuspa SH, Koehler B, Kulesz-Martin M, Hennings H: Clonal growth of mouse epidermal cells in medium with reduced calcium concentration. Journal of Investigative Dermatology. 1981, 76: 144-146. 10.1111/1523-1747.ep12525490.CrossRefPubMed Yuspa SH, Koehler B, Kulesz-Martin M, Hennings H: Clonal growth of mouse epidermal cells in medium with reduced calcium concentration. Journal of Investigative Dermatology. 1981, 76: 144-146. 10.1111/1523-1747.ep12525490.CrossRefPubMed
32.
go back to reference Greenhalgh DA, Welty DJ, Player A, Yuspa SH: Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proceedings of the National Academy of Sciences. 1990, 87: 643-647. 10.1073/pnas.87.2.643.CrossRef Greenhalgh DA, Welty DJ, Player A, Yuspa SH: Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proceedings of the National Academy of Sciences. 1990, 87: 643-647. 10.1073/pnas.87.2.643.CrossRef
33.
go back to reference Colburn NH, Wendel EJ, Abruzzo G: Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proceedings of the National Academy of Sciences. 1981, 78: 6912-6916. 10.1073/pnas.78.11.6912.CrossRef Colburn NH, Wendel EJ, Abruzzo G: Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proceedings of the National Academy of Sciences. 1981, 78: 6912-6916. 10.1073/pnas.78.11.6912.CrossRef
34.
go back to reference Yuspa SH, Kilkenny AE, Steinert PM, Roop DR: Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. The Journal of Cell Biology. 1989, 109: 1207-1217. 10.1083/jcb.109.3.1207.CrossRefPubMed Yuspa SH, Kilkenny AE, Steinert PM, Roop DR: Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. The Journal of Cell Biology. 1989, 109: 1207-1217. 10.1083/jcb.109.3.1207.CrossRefPubMed
35.
go back to reference Suzukawa K, Weber TJ, Colburn NH: AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environmental Health Perspectives. 2002, 110: 865-870.CrossRefPubMedPubMedCentral Suzukawa K, Weber TJ, Colburn NH: AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environmental Health Perspectives. 2002, 110: 865-870.CrossRefPubMedPubMedCentral
36.
go back to reference Dong Z, Cmarik JL, Wendel EJ, Colburn NH: Differential transformation efficiency but not AP-1 induction under anchorage-dependent and-independent conditions. Carcinogenesis. 1994, 15: 1001-1004. 10.1093/carcin/15.5.1001.CrossRefPubMed Dong Z, Cmarik JL, Wendel EJ, Colburn NH: Differential transformation efficiency but not AP-1 induction under anchorage-dependent and-independent conditions. Carcinogenesis. 1994, 15: 1001-1004. 10.1093/carcin/15.5.1001.CrossRefPubMed
37.
go back to reference Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, Bowden GT, Bode AM, Lee HJ, Dong Z: Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Research. 2008, 68: 946-955. 10.1158/0008-5472.CAN-07-3140.CrossRefPubMedPubMedCentral Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, Bowden GT, Bode AM, Lee HJ, Dong Z: Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Research. 2008, 68: 946-955. 10.1158/0008-5472.CAN-07-3140.CrossRefPubMedPubMedCentral
38.
go back to reference Eferl R, Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nature Reviews Cancer. 2003, 3: 859-868. 10.1038/nrc1209.CrossRefPubMed Eferl R, Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nature Reviews Cancer. 2003, 3: 859-868. 10.1038/nrc1209.CrossRefPubMed
39.
go back to reference Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999, 18: 6853-6866. 10.1038/sj.onc.1203239.CrossRefPubMed Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999, 18: 6853-6866. 10.1038/sj.onc.1203239.CrossRefPubMed
40.
go back to reference Plati J, Bucur O, Khosravi-Far R: Apoptotic cell signaling in cancer progression and therapy. Integative Biology. 2011, 3: 279-296. 10.1039/c0ib00144a.CrossRef Plati J, Bucur O, Khosravi-Far R: Apoptotic cell signaling in cancer progression and therapy. Integative Biology. 2011, 3: 279-296. 10.1039/c0ib00144a.CrossRef
41.
go back to reference Hennings H, Shores R, Wenk ML, Spangler EF, Tarone R, Yuspa SH: Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature. 1983, 304: 67-69. 10.1038/304067a0.CrossRefPubMed Hennings H, Shores R, Wenk ML, Spangler EF, Tarone R, Yuspa SH: Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature. 1983, 304: 67-69. 10.1038/304067a0.CrossRefPubMed
42.
go back to reference Ding M, Feng R, Wang SY, Bowman L, Lu Y, Qian Y, Castranova V, Jiang BH, Shi X: Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. Journal of Biological Chemistry. 2006, 281: 17359-17368. 10.1074/jbc.M600861200.CrossRefPubMed Ding M, Feng R, Wang SY, Bowman L, Lu Y, Qian Y, Castranova V, Jiang BH, Shi X: Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. Journal of Biological Chemistry. 2006, 281: 17359-17368. 10.1074/jbc.M600861200.CrossRefPubMed
43.
go back to reference Hehner SP, Heinrich M, Bork PM, Vogt M, Ratter F, Lehmann V, Schulze-Osthoff K, Dröge W, Schmitz ML: Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. Journal of Biological Chemistry. 1998, 273: 1288-1297. 10.1074/jbc.273.3.1288.CrossRefPubMed Hehner SP, Heinrich M, Bork PM, Vogt M, Ratter F, Lehmann V, Schulze-Osthoff K, Dröge W, Schmitz ML: Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. Journal of Biological Chemistry. 1998, 273: 1288-1297. 10.1074/jbc.273.3.1288.CrossRefPubMed
44.
go back to reference Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL, Merfort I: Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. Journal of Biological Chemistry. 2001, 276: 39713-39720. 10.1074/jbc.M101985200.CrossRefPubMed Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL, Merfort I: Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. Journal of Biological Chemistry. 2001, 276: 39713-39720. 10.1074/jbc.M101985200.CrossRefPubMed
45.
go back to reference Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 1996, 274: 787-789. 10.1126/science.274.5288.787.CrossRefPubMed Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 1996, 274: 787-789. 10.1126/science.274.5288.787.CrossRefPubMed
46.
go back to reference Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS: Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. Journal of Biological Chemistry. 1997, 272: 24113-24116. 10.1074/jbc.272.39.24113.CrossRefPubMed Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS: Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. Journal of Biological Chemistry. 1997, 272: 24113-24116. 10.1074/jbc.272.39.24113.CrossRefPubMed
47.
go back to reference Latimer M, Ernst MK, Dunn LL, Drutskaya M, Rice NR: The N-Terminal Domain of I kappa B alpha Masks the Nuclear Localization Signal (s) of p50 and c-Rel Homodimers. Molecular and Cellular Biology. 1998, 18: 2640-2649.CrossRefPubMedPubMedCentral Latimer M, Ernst MK, Dunn LL, Drutskaya M, Rice NR: The N-Terminal Domain of I kappa B alpha Masks the Nuclear Localization Signal (s) of p50 and c-Rel Homodimers. Molecular and Cellular Biology. 1998, 18: 2640-2649.CrossRefPubMedPubMedCentral
48.
go back to reference Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nature Cell Biology. 2002, 4: E131-E136. 10.1038/ncb0502-e131.CrossRefPubMed Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nature Cell Biology. 2002, 4: E131-E136. 10.1038/ncb0502-e131.CrossRefPubMed
49.
go back to reference Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. The EMBO journal. 1993, 12: 3879-3891.PubMedPubMedCentral Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. The EMBO journal. 1993, 12: 3879-3891.PubMedPubMedCentral
50.
go back to reference Angel P, Szabowski A, Schorpp-Kistner M: Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene. 2001, 20: 2413-2423. 10.1038/sj.onc.1204380.CrossRefPubMed Angel P, Szabowski A, Schorpp-Kistner M: Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene. 2001, 20: 2413-2423. 10.1038/sj.onc.1204380.CrossRefPubMed
51.
go back to reference Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nature Immunology. 2002, 3: 221-227.CrossRefPubMed Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nature Immunology. 2002, 3: 221-227.CrossRefPubMed
52.
go back to reference Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow–derived cells contributes to skin carcinogenesis. Cell. 2000, 103: 481-490. 10.1016/S0092-8674(00)00139-2.CrossRefPubMedPubMedCentral Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow–derived cells contributes to skin carcinogenesis. Cell. 2000, 103: 481-490. 10.1016/S0092-8674(00)00139-2.CrossRefPubMedPubMedCentral
53.
go back to reference Schneider-Stock R, Ghantous A, Bajbouj K, Saikali M, Darwiche N: Epigenetic mechanisms of plant-derived anticancer drugs. Frontiers in Bioscience. 2012, 17: 129-173. 10.2741/3919.CrossRef Schneider-Stock R, Ghantous A, Bajbouj K, Saikali M, Darwiche N: Epigenetic mechanisms of plant-derived anticancer drugs. Frontiers in Bioscience. 2012, 17: 129-173. 10.2741/3919.CrossRef
Metadata
Title
Sesquiterpene lactones isolated from indigenous Middle Eastern plants inhibit tumor promoter-induced transformation of JB6 cells
Authors
Melody Saikali
Akram Ghantous
Racha Halawi
Salma N Talhouk
Najat A Saliba
Nadine Darwiche
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2012
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-12-89

Other articles of this Issue 1/2012

BMC Complementary Medicine and Therapies 1/2012 Go to the issue